The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801.
 
Miguel-Ángel Berciano-Guerrero
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Eisai; Ipsen; Lilly; MSD Oncology; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Eisai; Ipsen; Lilly; MSD Oncology; Novartis; Pierre Fabre
Research Funding - Novartis (Inst)
 
Elisabeth Perez-Ruiz
Consulting or Advisory Role - Novartis
 
Eva Muñoz Couselo
Honoraria - BMS; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; MSD; Novartis; Pierre Fabre; Sanofi
 
Jose Luis Manzano
No Relationships to Disclose
 
Pablo Cerezuela-Fuentes
Consulting or Advisory Role - Pierre Fabre
Speakers' Bureau - MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Novartis; Pierre Fabre
 
Pablo Ayala de Miguel
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
 
Ainara Soria
No Relationships to Disclose
 
Almudena García Castaño
Speakers' Bureau - Bristol-Myers Squibb; MSD; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer; Pierre Fabre
 
Guillermo Crespo
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Eisai; EUSA Pharma; Merck; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Ipsen; Janssen Oncology; MSD Oncology; Roche
 
Teresa Puértolas
No Relationships to Disclose
 
Carlos Aguado De La Rosa
Consulting or Advisory Role - AstraZeneca; MSD; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Novartis; Pfizer; Pierre Fabre; Roche
Research Funding - AstraZeneca; Mirati Therapeutics; MSD
Travel, Accommodations, Expenses - Pierre Fabre
 
Lourdes Gutiérrez Sanz
No Relationships to Disclose
 
Rafael López Castro
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Roche; Takeda
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; MSD Oncology; Novartis; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD; Novartis; Roche; Takeda
 
Enrique Espinosa
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - MSD Oncology
Research Funding - Roche (I)
 
Maria José Lecumberri
No Relationships to Disclose
 
Margarita Majem
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Helsinn Therapeutics; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Roche
 
Javier Medina Martinez
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Lorena Bellido
Honoraria - AstraZeneca Spain
Consulting or Advisory Role - Sanofi
 
Luis Antonio Fernández-Morales
Honoraria - Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Salvador Martin-Algarra
Consulting or Advisory Role - AstraZeneca (I)
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); Roche (I)
Other Relationship - AstraZeneca (I)